First Eagle Investment Management
TMCI icon

First Eagle Investment Management’s Treace Medical Concepts TMCI Stock Holding History

First Eagle Investment Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,462,983
Closed -$3.58M – 452
2025
Q4 		$3.58M Buy
1,462,983
+224,088
+18% +$973K 0.01% 282
2025
Q3 		$8.31M Buy
1,238,895
+330,866
+36% +$2.16M 0.02% 192
2025
Q2 		$5.34M Buy
908,029
+409,105
+82% +$2.67M 0.01% 247
2025
Q1 		$4.19M Buy
+498,924
New +$4.48M 0.01% 273

Other funds holding TMCI

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
CIBC Bancorp USA
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

First Eagle Investment Management's TMCI Position: Q1 2026 in Review

First Eagle Investment Management sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 1,462,983 shares — an estimated $3.58M sold.

First Eagle Investment Management first reported a position in TMCI in Q1 2025 and held it in 4 quarters. The position peaked at $8.31M in Q3 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • First Eagle Investment Management reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • First Eagle Investment Management sold 1,462,983 Treace Medical Concepts shares in Q1 2026, an estimated $3.58M.
  • First Eagle Investment Management first reported a position in Treace Medical Concepts in Q1 2025 and held it in 4 quarters.
  • First Eagle Investment Management's Treace Medical Concepts position peaked at $8.31M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on First Eagle Investment Management's 13F filing for Q1 2026, filed 12 May 2026.